LIGAND PHARMACEUTICALS INC (LGND)
Across 83 earnings reports since Nov 09, 2004, LIGAND PHARMACEUTICALS INC (LGND) has a clear post-earnings pattern. It moves ±4.97% on average after reporting and finishes higher 49.4% of the time. Its largest post-earnings gain was +19.86% (Feb 27, 2024) and its largest decline was -12.47% (Feb 20, 2008). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings reactions
How LGND moved on each past earnings report.
Earnings Impact
Total Earnings
83
Avg Abs. Movement
±4.97%
Positive %
49.4%
Negative %
50.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☀ PRE | -9.37% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +2.5% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +9.37% | open_in_new |
| Aug 07, 2025 | ☀ PRE | +2.75% | open_in_new |
Earnings Count
83
Total earnings in dataset
Avg Abs. Movement
±4.97%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| S-8 | 20260722 | open_in_new SEC.gov |
| 8-K | 20260714 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 144 | 20260701 | open_in_new SEC.gov |
| 8-K | 20260625 | open_in_new SEC.gov |
| 8-K | 20260622 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 144 | 20260616 | open_in_new SEC.gov |
Frequently asked about LGND earnings
When does LIGAND PHARMACEUTICALS INC report earnings next? expand_more
LIGAND PHARMACEUTICALS INC (LGND)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LGND stock move after earnings? expand_more
Over 83 reports, LGND has moved an average of ±4.97% the session after earnings, closing higher 49.4% of the time.
What was LGND's biggest post-earnings move? expand_more
LGND's largest post-earnings gain on record was +19.86% on Feb 27, 2024, and its largest decline was -12.47% on Feb 20, 2008.
Where can I find LIGAND PHARMACEUTICALS INC's SEC filings? expand_more
All of LIGAND PHARMACEUTICALS INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- Allegiant Travel CO (ALGT) earnings 2026-08-03
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-08-03
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04